|
|
|
|
pmid:
|
van Kooten F et al. |
Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. |
1999 |
Stroke |
pmid:10066850
|
Catella-Lawson F et al. |
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. |
1999 |
J. Pharmacol. Exp. Ther. |
pmid:10215647
|
Morrow JD et al. |
Increased formation of thromboxane in vivo in humans with mastocytosis. |
1999 |
J. Invest. Dermatol. |
pmid:10417625
|
Mills JL et al. |
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. |
1999 |
JAMA |
pmid:10432033
|
van Kooten F et al. |
Increased thromboxane biosynthesis is associated with poststroke dementia. |
1999 |
Stroke |
pmid:10436098
|
Nishimaki S and Seki K |
An imbalance between prostacyclin and thromboxane in relation to cerebral blood flow in neonates with maternal preeclampsia. |
1999 |
Prostaglandins Other Lipid Mediat. |
pmid:10482286
|
Fruzzetti F et al. |
Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects. |
1999 |
Thromb. Haemost. |
pmid:10494782
|
Pirich C et al. |
Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. |
1999 |
Thromb. Res. |
pmid:10588465
|
Mizugaki M et al. |
Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method. |
1999 |
Prostaglandins Other Lipid Mediat. |
pmid:10593167
|
Hishinuma T et al. |
Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic. |
1999 |
Prostaglandins Other Lipid Mediat. |
pmid:10593168
|
Ferro D et al. |
Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. |
1999 |
Arthritis Rheum. |
pmid:10616019
|
Perneby C et al. |
Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. |
1999 |
Thromb. Res. |
pmid:10632465
|
Romano M et al. |
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide. |
2000 |
J. Investig. Med. |
pmid:10822898
|
Mizugaki M |
[Microdetermination of eicosanoids using mass spectrometry]. |
2000 |
Nippon Yakurigaku Zasshi |
pmid:10876809
|
Patrignani P et al. |
Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. |
2000 |
Circulation |
pmid:10920066
|
Wang JS et al. |
Effect of strenuous arm exercise on oxidized-LDL-potentiated platelet activation in individuals with spinal cord injury. |
2000 |
Thromb. Haemost. |
pmid:10928481
|
Belton O et al. |
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. |
2000 |
Circulation |
pmid:10952950
|
Ciabattoni G et al. |
In vivo lipid peroxidation and platelet activation in cystic fibrosis. |
2000 |
Am. J. Respir. Crit. Care Med. |
pmid:11029317
|
Suzuki N et al. |
Difference in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:11060902
|
Cracowski JL et al. |
Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. |
2001 |
Arthritis Rheum. |
pmid:11352247
|
Fritsma GA et al. |
Monitoring the antiplatelet action of aspirin. |
2001 |
JAAPA |
pmid:11523339
|
Davì G et al. |
Oxidative stress and platelet activation in homozygous homocystinuria. |
2001 |
Circulation |
pmid:11535567
|
Martinuzzo ME et al. |
Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies. |
2001 |
Br. J. Haematol. |
pmid:11564073
|
Llinás MT et al. |
Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. |
2001 |
Am. J. Physiol. Renal Physiol. |
pmid:11592955
|
Nüsing RM et al. |
Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. |
2001 |
Clin. Pharmacol. Ther. |
pmid:11673754
|
McConnell JP et al. |
Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke. |
2001 |
Neurosci. Lett. |
pmid:11684346
|
Wang ZY et al. |
Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease. |
2001 |
Blood Coagul. Fibrinolysis |
pmid:11685040
|
Mita H et al. |
Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. |
2001 |
Allergy |
pmid:11703219
|
Hishinuma T et al. |
Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. |
2001 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:11728171
|
Kurokawa K et al. |
Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients. |
2001 |
Chest |
pmid:11742908
|
Bruno A et al. |
Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients. |
2002 |
Stroke |
pmid:11779889
|
Obase Y et al. |
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. |
2002 |
Chest |
pmid:11796443
|
Eikelboom JW et al. |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. |
2002 |
Circulation |
pmid:11940542
|
Hayashi M et al. |
The levels of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy. |
2002 |
Acta Obstet Gynecol Scand |
pmid:11966476
|
Nakamura H et al. |
Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis. |
2001 Nov-Dec |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:11993724
|
Cipollone F et al. |
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. |
2002 |
Circulation |
pmid:12135935
|
Davì G et al. |
Platelet activation in obese women: role of inflammation and oxidant stress. |
2002 Oct 23-30 |
JAMA |
pmid:12387653
|
Saareks V et al. |
Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. |
2002 |
Pharmacol. Toxicol. |
pmid:12403056
|
Sinzinger H |
Comments on "Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications". |
2002 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12445490
|
Minuz P et al. |
Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. |
2002 |
Circulation |
pmid:12451006
|
Hayashi M et al. |
Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia. |
2002 Nov-Dec |
Eur. J. Haematol. |
pmid:12460234
|
Fiorucci S et al. |
NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide. |
2002 |
Circulation |
pmid:12473561
|
Rouvier J et al. |
Aspirin resistance. |
2002 |
Circulation |
pmid:12473569
|
Cipollone F et al. |
Modulation of aspirin-insensitive eicosanoid biosynthesis by 6-methylprednisolone in unstable angina. |
2003 |
Circulation |
pmid:12515743
|
Kudolo GB et al. |
Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. |
2002 |
Thromb. Res. |
pmid:12590952
|
Tsuruta LR et al. |
Characterization of 11-dehydro-thromboxane B2 recombinant antibody obtained by phage display technology. |
2003 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12628223
|
Bosetti F et al. |
Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. |
2003 |
J. Neurochem. |
pmid:12694395
|
Hart RG et al. |
Aspirin dosage and thromboxane synthesis in patients with vascular disease. |
2003 |
Pharmacotherapy |
pmid:12741431
|
Davì G et al. |
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. |
2003 |
Circulation |
pmid:12810609
|
De Cristofaro R et al. |
Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. |
2003 |
J. Thromb. Haemost. |
pmid:12871497
|
Wolfram R et al. |
Daily prickly pear consumption improves platelet function. |
2003 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12878452
|
Kumlin M et al. |
Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1320824
|
Landolfi R et al. |
Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. |
1992 |
Blood |
pmid:1327286
|
Uyama O et al. |
Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction. |
1992 |
Intern. Med. |
pmid:1392173
|
Tohgi H et al. |
Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. |
1992 |
Stroke |
pmid:1412574
|
Tanaka S et al. |
High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. |
2003 |
Chest |
pmid:14605047
|
Minuz P et al. |
Determinants of platelet activation in human essential hypertension. |
2004 |
Hypertension |
pmid:14656953
|
Böhm E et al. |
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. |
2004 |
J. Biol. Chem. |
pmid:14668348
|
Katoh K |
Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus. |
1992 |
Diabetes Res. Clin. Pract. |
pmid:1478157
|
Bruno A et al. |
Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. |
2004 |
Stroke |
pmid:14963281
|
Ikonomidis I et al. |
Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor. |
2004 |
Heart |
pmid:15020512
|
Dippel DW et al. |
What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? |
2004 |
Cerebrovasc. Dis. |
pmid:15026612
|
Capone ML et al. |
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. |
2004 |
Circulation |
pmid:15037526
|
Leonhardt A et al. |
Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children. |
1992 |
Acta Paediatr. |
pmid:1511190
|
Suzuki N et al. |
Quantitative liquid chromatography-tandem mass spectrometric analysis of 11-dehydro TXB2 in urine. |
2004 |
Prostaglandins Other Lipid Mediat. |
pmid:15165035
|
Riutta A et al. |
Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay. |
1992 |
Anal. Biochem. |
pmid:1519756
|
Ferroni P et al. |
Platelet activation in type 2 diabetes mellitus. |
2004 |
J. Thromb. Haemost. |
pmid:15304032
|
Perneby C et al. |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment. |
2004 |
Thromb. Res. |
pmid:15381386
|
Hennekens CH et al. |
Terms and conditions: semantic complexity and aspirin resistance. |
2004 |
Circulation |
pmid:15381661
|
Rebuzzi AG et al. |
Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis. |
1992 |
Am. Heart J. |
pmid:1539506
|
Davì G et al. |
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15472127
|
Vainio M et al. |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. |
2004 |
Acta Obstet Gynecol Scand |
pmid:15548142
|
Gonzalez-Conejero R et al. |
Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? |
2005 |
Stroke |
pmid:15604423
|
Oishi M and Mochizuki Y |
beta-Thromboglobulin and 11-dehydrothromboxane B in tension-type headache. |
1998 |
Headache |
pmid:15613179
|
Sciulli MG et al. |
Platelet activation in patients with colorectal cancer. |
2005 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:15626589
|
Saloheimo P et al. |
Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. |
2005 |
Thromb. Res. |
pmid:15733969
|
De Candia E et al. |
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. |
2005 |
Int. J. Cardiol. |
pmid:15837078
|
Ikonomidis I et al. |
Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. |
2005 |
Am. Heart J. |
pmid:15894964
|
Reinke M |
Monitoring thromboxane in body fluids: a specific ELISA for 11-dehydrothromboxane B2 using a monoclonal antibody. |
1992 |
Am. J. Physiol. |
pmid:1590375
|
Christman BW et al. |
An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. |
1992 |
N. Engl. J. Med. |
pmid:1603138
|
Haubelt H et al. |
Can platelet function tests predict the clinical efficacy of aspirin? |
2005 |
Semin. Thromb. Hemost. |
pmid:16149017
|
Coppola A et al. |
Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. |
2005 |
Br. J. Haematol. |
pmid:16173969
|
Kataoka M et al. |
A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. |
2005 |
Am. J. Respir. Crit. Care Med. |
pmid:16192456
|
Falco A et al. |
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. |
2005 |
Atherosclerosis |
pmid:16285996
|
Lin JS et al. |
The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence. |
1992 |
J. Urol. |
pmid:1635125
|
Santilli F et al. |
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. |
2006 |
J. Am. Coll. Cardiol. |
pmid:16412866
|
Baltzer WI et al. |
Measurement of urinary 11-dehydro-thromboxane B2 excretion in dogs with gastric dilatation-volvulus. |
2006 |
Am. J. Vet. Res. |
pmid:16426215
|
Ciabattoni G et al. |
Determinants of platelet activation in Alzheimer's disease. |
2007 |
Neurobiol. Aging |
pmid:16442186
|
Laleman W et al. |
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. |
2006 |
Eur. J. Clin. Invest. |
pmid:16620286
|
Markuszewski L et al. |
Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? |
2006 |
Basic Clin. Pharmacol. Toxicol. |
pmid:16635110
|
Ohmori T et al. |
Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients. |
2006 |
J. Thromb. Haemost. |
pmid:16706971
|
Van Geet C et al. |
Possible platelet contribution to pathogenesis of transient neonatal hyperammonaemia syndrome. |
1991 |
Lancet |
pmid:1670726
|
Faraday N et al. |
Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. |
2006 |
Am. J. Cardiol. |
pmid:16950183
|
Renda G et al. |
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. |
2006 |
Clin. Pharmacol. Ther. |
pmid:16952493
|
Maree AO and Fitzgerald DJ |
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. |
2007 |
Circulation |
pmid:17452618
|
Lee CR et al. |
Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. |
2008 |
Clin. Pharmacol. Ther. |
pmid:17495879
|
Chakroun T et al. |
Screening for aspirin resistance in stable coronary artery patients by three different tests. |
2007 |
Thromb. Res. |
pmid:17553552
|
Heistein LC et al. |
Aspirin resistance in children with heart disease at risk for thromboembolism: prevalence and possible mechanisms. |
2008 |
Pediatr Cardiol |
pmid:17896127
|
Schwartz JI et al. |
Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. |
2007 |
J Clin Pharmacol |
pmid:17925592
|